implanted hardware or other material that would prohibit treatment planning or delivery
chemotherapy for a malignancy within the previous 5 years
history of an invasive malignancy (other than this prostate cancer,or basal or squamous skin cancers) within prior 5 years
hormone ablation for 2 months prior to treatment or during treatment

NCT01581749_exc_T2
Procedure
chemotherapy
NCT01581749_exc_T3
Condition
malignancy
NCT01581749_exc_T4
Temporal
within the previous 5 years
NCT01581749_exc_T5
Condition
invasive malignancy
NCT01581749_exc_T6
Negation
other than
NCT01581749_exc_T7
Condition
prostate cancer
NCT01581749_exc_T8
Condition
squamous skin cancers
NCT01581749_exc_T9
Condition
sal o in cancers)
NCT01581749_exc_T10
Scope
prostate cancer,or basal or squamous skin cancers
NCT01581749_exc_T11
Temporal
within prior 5 years
NCT01581749_exc_T12
Scope
invasive malignancy (other than this prostate cancer,or basal or squamous skin cancers
NCT01581749_exc_T13
Procedure
hormone ablation
NCT01581749_exc_T14
Temporal
for 2 months prior to treatment
NCT01581749_exc_T15
Reference_point
treatment
NCT01581749_exc_T16
Temporal
during treatment
NCT01581749_exc_T17
Reference_point
treatment
NCT01581749_exc_T18
Scope
for 2 months prior to treatment or during treatment